Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: Immunophenotypic characterization and differentiation potential

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Barberini, Danielle Jaqueta ^a   Freitas, Natália Pereira Paiva ^a   Magnoni, Mariana Sartori ^a   Maia, Leandro ^a   Listoni, Amanda Jerônimo ^a   Heckler, Marta Cristina ^a   Sudano, Mateus Jose ^b   Golim, Marjorie Assis ^a   Da Cruz Landim Alvarenga, Fernanda ^a   Amorim, Rogério Martins ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THY 1 ANTIGEN; HLA DR ANTIGEN;

ADIPOGENESIS; ADIPOSE TISSUE MESENCHYMAL STEM CELL; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; BONE MARROW MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CHONDROGENESIS; CONTROLLED STUDY; EQUIDAE; FEASIBILITY STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MESODERM; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL CULTURE; UMBILICAL CORD MESENCHYMAL STEM CELL; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; HORSE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; UMBILICAL CORD;

EQUIDAE;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD44; ANTIGENS, THY-1; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HLA-DR ALPHA-CHAINS; HORSES; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; UMBILICAL CORD;

EID: 84898539033     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt414     Document Type: Article

References (51)

1. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Chamberlain G, Fox J, Ashton B, Middleton J, Stem Cells 2007 25 2739 2749 10.1634/stemcells.2007- 0197 17656645 (Pubitemid 350127858)
2. Cell delivery therapeutics for musculoskeletal regeneration. Nöth U, Rackwitz L, Steinert AF, Tuan RS, Adv Drug Deliv Rev 2010 62 765 783 10.1016/j.addr.2010.04.004 20398712
3. Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Taylor SE, Smith RK, Clegg PD, Equine Vet J 2007 39 172 180 10.2746/042516407X180868 17378447 (Pubitemid 351716181)
4. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horse: preliminary study. Guest DJ, Smith MR, Allen WR, Equine Vet J 2008 40 178 181 10.2746/042516408X276942 18267891 (Pubitemid 351717168)
5. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses. Carrade DD, Owens SD, Galuppo LD, Vidal MA, Ferraro GL, Librach F, Buerchler S, Friedman MS, Walker NJ, Borjesson DL, Cytotherapy 2011 13 419 430 10.3109/14653249.2010.536213 21105841
6. Mesenchymal stem cells: a promising candidate in regenerative medicine. Chen Y, Shao JZ, Xiang LX, Dong XJ, Zhang GR, Int J Biochem Cell Biol 2008 40 815 820 10.1016/j.biocel.2008.01.007 18295530
7. Hepatocyte differentiation of mesenchymal stem cells. Wu X, Tao R, Hepatobiliary Pancreat Dis Int 2012 11 360 371 10.1016/S1499-3872(12)60193-3 22893462
8. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. Reed SA, Johnson SE, J Cell Physiol 2008 215 329 336 10.1002/jcp.21312 17929245 (Pubitemid 351468944)
9. Commercial cell-based therapies for musculoskeletal injuries in horses. Gutierrez-Nibeyro SD, Vet Clin North Am Equine Pract 2011 27 363 371 10.1016/j.cveq.2011.04.001 21872764
10. Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99 m) Tc-HMPAO. Sole A, Spriet M, Galuppo LD, Padgett KA, Borjesson DL, Wisner ER, Brosnan RJ, Vidal MA, Equine Vet J 2012 44 594 599 10.1111/j.2042-3306.2011.00530.x 22212017
11. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Carvalho AM, Alves AL, Golim MA, Moroz A, Hussni CA, Oliveira PG, Deffune E, Vet Immunol Immunopathol 2009 132 303 306 10.1016/j.vetimm.2009.06.014 19647331
12. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue. Ranera B, Lyahyaia J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I, Vet Immunol Immunopathol 2011 144 147 154 10.1016/j.vetimm.2011.06.033 21782255
13. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment. Lange-Consiglio A, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F, Equine Vet J 2013 45 737 744 10.1111/evj.12052 23527626
14. Umbilical cord blood stem cells. Rogers I, Casper RF, Best Pract Res Clin Obstet Gynaecol 2004 18 893 908 10.1016/j.bpobgyn.2004.06.004 15582545 (Pubitemid 40012026)
15. Defining the expression of marker genes in equine mesenchymal stromal cells. Guest DJ, Ousey JC, Smith MR, Stem Cells Cloning 2008 1 1 9 24198500
16. Flow cytometric characterization of culture expanded multipotent mesenchymal stromal cells (MSCs) from horse adipose tissue: towards the definition of minimal stemness criteria. Pascuccia L, Curinab G, Mercatia F, Marinib C, Dall'Aglio C, Paternesi B, Ceccarelli P, Vet Immunol Immunopathol 2011 144 499 506 10.1016/j.vetimm.2011.07.017 21839521
17. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A, Theriogenology 2010 75 1431 1443 21196039
18. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease. Borjesson DL, Peroni JF, Clin Lab Med 2011 31 109 123 10.1016/j.cll.2010.12.001 21295725
19. Equine cellular therapy-from stall to bench to bedside? Burk J, Badylak SF, Kelly J, Brehm W, Cytometry A 2013 83 103 113 23081833
20. Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL, Cell Med 2012 4 1 11 10.3727/215517912X647217 23152950
21. Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells. Ranera B, Ordovás L, Lyahyai J, Bernal ML, Fernandes F, Remacha AR, Romero A, Vázquez FJ, Osta R, Cons C, Varona L, Zaragoza P, Martín-Burriel I, Rodellar C, Equine Vet J 2012 44 33 42 10.1111/j.2042-3306.2010.00353.x 21668489
22. Characterization and differentiation of equine umbilical cord-derived matrix cells. Hoynowski SM, Fry MM, Gardner BM, Leming MT, Tucker JR, Black L, Sand T, Mitchell KE, Biochem Biophys Res Commun 2007 362 347 353 10.1016/j.bbrc.2007.07.182 17719011 (Pubitemid 47334921)
23. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells. Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro D, Cremonesi F, Vet Res Commun 2011 35 103 121 10.1007/s11259-010-9457-3 21193959
24. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E, Cytometry A 2012 81A 312 323 10.1002/cyto.a.22026
25. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for cellular therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
26. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM, Cytotherapy 2013 15 641 648 10.1016/j.jcyt.2013.02.006 23570660
27. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C, Brehm W, Vet J 2013 195 98 106 10.1016/j.tvjl.2012.06.004 22841420
28. Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Richardson LE, Dudhia J, Clegg PD, Smith R, Trends Biotechnol 2007 25 409 416 10.1016/j.tibtech.2007.07.009 17692415 (Pubitemid 350147117)
29. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL, Am J Vet Res 2008 69 928 937 10.2460/ajvr.69.7.928 18593247
30. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005- 0342 16410387 (Pubitemid 44464698)
31. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Carrade DD, Affolter VK, Outerbridge CA, Watson JL, Galuppo LD, Buerchler S, Kumar V, Walker NJ, Borjesson DL, Cytotherapy 2011 13 1180 1192 10.3109/14653249.2011.602338 21899391
32. Anti-inflammatory and immunomodulatory activities of stem cells. Peroni JF, Borjesson DL, Vet Clin North Am Equine Pract 2011 27 351 362 10.1016/j.cveq.2011.06.003 21872763
33. Mesenchymal stem cells avoid allogeneic rejection. Ryan JM, Barry FP, Murphy JM, Mahon BP, J Inflamm (Lond) 2005 2 8 10.1186/1476-9255-2-8 16045800 (Pubitemid 41364607)
34. Immunophenotypic, immunocytochemistry, ultrastructural, and cytogenetic characterization of mesenchymal stem cells from equine bone marrow. Maia L, Landim-Alvarenga FC, Da Mota LS, De Assis Golim M, Laufer-Amorim R, De Vita B, Barberini DJ, Listoni AJ, De Moraes CN, Heckler MC, Amorim RM, Microsc Res Tech 2013 76 618 624 10.1002/jemt.22208 23533133
35. Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix. Corradetti B, Lange-Consiglio A, Barucca M, Cremonesi F, Bizzaro D, Cell Prolif 2011 44 330 342 10.1111/j.1365-2184.2011.00759.x 21645152
36. Collection of equine cord blood and placental tissues in 40 thoroughbred mares. Bartholomew S, Owens SD, Ferraro GL, Carrade DD, Lara DJ, Librach FA, Borjesson DL, Galuppo LD, Equine Vet J 2009 41 724 728 10.2746/042516409X429446 20095217
37. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Koerner J, Nesic D, Romero JD, Brehm W, Mainil-Varlet P, Grogan SP, Stem Cells 2006 24 1613 1619 10.1634/stemcells.2005- 0264 16769763 (Pubitemid 44464679)
38. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, Spadari A, Galli C, Lazzari G, Vet Res Commun 2009 33 811 821 10.1007/s11259-009-9229-0 19472068
39. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Vidal MA, Walker NJ, Napoli E, Borjesson DL, Stem Cells Dev 2012 21 273 283 10.1089/scd.2010.0589 21410356
40. Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Toupadakis CA, Wong A, Genetos DC, Cheung WK, Borjesson DL, Ferraro GL, Galuppo LD, Leach JK, Owens SD, Yellowley CE, Am J Vet Res 2010 71 1237 1245 10.2460/ajvr.71.10.1237 20919913
41. Hydrolyzed fish collagen induced chondrogenic differentiation of equine adipose tissue-derived stromal cells. Raabe O, Reich C, Wenisch S, Hild A, Burg-Roderfeld M, Siebert HC, Arnhold S, Histochem Cell Biol 2010 134 545 554 10.1007/s00418-010-0760-4 21076963
42. Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM, Vet Surg 2007 36 613 622 10.1111/j.1532-950X.2007.00313.x 17894587 (Pubitemid 47480926)
43. Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Troyer DL, Weiss ML, Stem Cells 2008 26 591 599 10.1634/stemcells.2007-0439 18065397
44. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B, Reproduction 2012 143 455 468 10.1530/REP-10-0408 22274885
45. In vitro mesenchymal trilineage differentiation and extracellular matrix production by adipose and bone marrow derived adult equine multipotent stromal cells on a collagen scaffold. Xie L, Zhang N, Marsano A, Vunjak-Novakovic G, Zhang Y, Lopez MJ, Stem Cell Rev 2013 9 858 872 10.1007/s12015-013-9456-1 23892935
46. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O, Johnson JR, Moore RM, Gimble JM, Vet Surg 2008 37 713 724 10.1111/j.1532-950X.2008.00462.x 19121166
47. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Radcliffe CH, Flaminio MJ, Fortier LA, Stem Cells Dev 2010 19 269 281 10.1089/scd.2009.0091 19604071
48. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells. Braun J, Hack A, Weis-Klemm M, Conrad S, Treml S, Kohler K, Walliser U, Skutella T, Aicher WK, Am J Vet Res 2010 71 1228 1236 10.2460/ajvr.71.10.1228 20919912
49. Multipotent stem cells from umbilical cord: cord is richer than blood! Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M, Stem Cells 2008 26 146 150 10.1634/stemcells.2007-0381 17932423
50. Isolamento, caracterização ediferenciação de células-tronco mesenquimais do líquido amniótico equino obtido em diferentes idades gestacionais. De Vita B, Campos LL, Listoni AJ, Maia L, Sudano MJ, Curcio BR, Landim-Alvarenga FC, Prestes NC, Pesq Vet Bras 2013 33 535 542 10.1590/S0100-736X2013000400019
51. Characterization of equine adipose tissue-derived progenitor cells before and after cryopreservation. Mambelli LI, Santos EJ, Frazão PJ, Chaparro MB, Kerkis A, Zoppa AL, Kerkis I, Tissue Eng Part C Methods 2009 15 87 94 19196122